ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes
- PMID: 36537534
- PMCID: PMC10107518
- DOI: 10.1111/pedi.13443
ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes
Keywords: glucagon; hypoglycemia; impaired awareness of hypoglycemia.
Conflict of interest statement
Dr Dovc received speaker's honoraria from Abbott, Pfizer, Novo Nordisk, and Eli Lilly and Advisory Board honoraria from Sanofi and Pfizer. Dr Dovc is a member of the European Commission Expert panel for Medical Devices for Endocrinology and Diabetes. Dr Abraham received speaker's honoraria for educational sessions organized by Medtronic Australia and Eli Lilly.
References
-
- Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008;14(6):750‐756. - PubMed
-
- Johnson SR, Cooper MN, Davis EA, Jones TW. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with type 1 diabetes and their parents. Diabet Med. 2013;30(9):1126‐1131. - PubMed
-
- Minimizing hypoglycemia in diabetes. Diabetes Care. 2015;38(8):1583‐1591. - PubMed
-
- Abraham MB, Nicholas JA, Smith GJ, et al. Reduction in hypoglycemia with the predictive low‐glucose management system: a long‐term randomized controlled trial in adolescents with type 1 diabetes. Diabetes Care. 2018;41(2):303‐310. - PubMed
-
- Battelino T, Nimri R, Dovc K, Phillip M, Bratina N. Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(6):764‐770. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical